Glucotrack(us:GCTK)

0.2250

+28.94%

Updated on 2025-04-02

Open:0.1760
Close:0.2250
High:0.2380
Low:0.1720
Prev Close:0.1745
Volume:12.83M
Turnover:3.06M
Turnover Ratio:50.14%
Shares:25.59M
MarketCap:5.76M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-309299470.55%207
2024-03-31111569450.59%315
2023-12-31106077452.91%125
2023-09-309226446510.84%412
2023-06-308215193810.30%413
2023-03-315544190.35%012
2022-12-315484190.31%200
2022-09-304380720.25%101
dateorgNametotalratiochangeShareschangeRatio
2024-03-31Sabby Management, Llc1229270.46%3714543.30%
2024-03-31Alerus Financial Na138560.05%0
2024-03-31Virtue Capital Management, Llc60000.02%6000
2024-03-31Accurate Wealth Management, Llc44200.02%0
2024-03-31Citadel Advisors Llc44050.02%-3432-43.79%
2024-03-31Susquehanna International Group, Llp27370.01%2737
2024-03-31Renaissance Technologies Llc26000.01%2600
2024-03-31Boston Financial Mangement Llc0-5274
2024-03-31Virtu Financial Llc0-3783
2024-03-31Ubs Group Ag0-960

About

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.
Address:301 Route 17 North,Suite 800

Market Movers